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Aim: Data about cardiac response to recurrent electroconvulsive therapy (ECT) in
healthy heart are lacking. We investigated the effects of recurrent (seven times) ECT
on cardiac function to reveal the presence or absence of adaptive changes in patients
free of cardiovascular disease.
Method: We enrolled twenty-three patients who underwent to ECT with different
psychiatric disorders. Echocardiographic examination including diastolic mitral inﬂow
and tissue Doppler features was recorded before and after total seven times ECT in all
patient.
Result: Male/Female ratio was 11/12. Mean age was 37 (19-71). There was not
a signiﬁcant difference in mitral E wave velocities and tissue Doppler E’ velocities
after the ﬁrst ECT compared to baseline values. (p¼0.161, p¼0.083). The results
were similar after the latest ECT session. (p¼0.463, p¼0.310). However there was
a signiﬁcant increase in transmitral A wave velocity after the ﬁrst and the seventh ECT
session compared to baseline values (p¼0.008, p¼0.017).
Conclusion: Our study revealed that mitral diastolic inﬂow A wave velocity was
increased 20 minutes after the ECT and this increase persisted after recurrent ECT
sessions in apparently healthy hearts. This ﬁnding is considered possibly as the
indicator of acutely increased sympathetic tone.
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Backgrounds: Chronic obstructive pulmonary disease (COPD) has many comor-
bidities such as coronary artery disease (CAD) and lung cancer.
Objectives: We analysed that impact of COPD on intensity and severity of coronary
lesions on the angiogram in the groups of patients with COPD according to the Global
Initiative for Obstructive Lung Disease (GOLD) grades updated in 2011.
Methods: The study included 102 patients with diagnosed COPD and 80 randomly
selected subjects without any pulmonary disease who underwent coronary angiography.
According to the GOLD grade for COPD, patients were divided into 4 groups: A, B, C
and D. The severity and extent of CAD were determined using Gensini score.
Results: There were no signiﬁcantly differences in age, body mass index, smoking,
plasma lipid levels, frequency of hypertension and diabetes. The mean Gensini score
in COPD (25.732.9) was signiﬁcantly higher than controls (17.524.8, p¼0.01).
While Gensini score was the highest level in group D (64.934.9), it was the lowest
level in group A (10.219.4, p¼0.0001). COPD was independently predictive for
Gensini score after a multivariate logistic regression analysis (odds ratio 1.625; 95%
conﬁdence interval 2.172–12.232; p¼0.001).
Conclusions: Severity and intensity of coronary atherosclerosis increases in accor-
dance with increases in the GOLD grades.Cardiac Imaging
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Sclerostin is a protein expressed by osteocytes and has been shown to be a good
predictor for bone formation in patients with chronic kidney disease. Sclerostin was
only recently identiﬁed in the subendothelial layer of the human aortic intima,C64 JACC Vsuggesting a possible role in the pathogenesis of aortic valve calciﬁcation. The aim of
this study was to evaluate the relationship between serum sclerostin levels and aortic
valve calciﬁcation in maintenance hemodialysis patients.
Materials-Methodology: 101 patients (48 females and 53 males, mean age: 5912
years, mean hemodialysis vintage: 5628 months) were included in a cross-sectional
study. Serum sclerostin levels were measured by ELISA (R&D Systems, Minneapolis,
MN). All patients underwent unenhanced, electrocardiography-triggered dual-source
computed tomography of the heart.
Results: Patients with aortic valve calciﬁcation had signiﬁcantly higher serum
sclerostin levels as compared to patients with no calciﬁed aortic valves (28131171
vs 13621190 pg/mL, p<0.001). The patients are grouped according to tertiles of
serum sclerostin levels as follows: (1st tertile: serum sclerostin levels 370 pg/ml;
2nd tertile: 370<serum sclerostin levels<2282 pg/ml; 3rd tertile: serum sclerostin
levels 2282 pg/ml. The frequencies of aortic valve calciﬁcation were 36% (5 in 14
cases), 58% (30 in 52 cases) and 94% (33 in 35 cases), respectively (p<0.0001 for the
trend). In the multivariable regression analysis, age (B¼0.46, p¼0.015) and serum
sclerostin levels (B¼0.35, p¼0.044) were independent factors for aortic valve
calciﬁcation.
Conclusion: Further studies are needed to identify sclerostin as a pathogenetic factor
or a suitable biomarker or a therapeutic target for AVC in maintenance hemodialysis
population.General
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Introduction: Arteriovenous ﬁstula (AVF), an important option for hemodialysis
vascular access, is prone to recurrent stenosis and thrombosis. Sclerostin, a novel
protein secreted by the osteocytes, has been recently shown to be associated with renal
osteodystrophy. The objective of this prospective study was to determine if there was
an association between serum sclerostin levels, AVF calciﬁcation and one-year AVF
survival.
Material and Methods: The study involved 350 hemodialysis patients followed for
12 months. AVF calciﬁcation was evaluated as previously described. AVF surveil-
lance was conducted by clinical and ultrasonographic evaluation. AVF dysfunction is
diagnosed on angiographic basis.
Results: Serum sclerostin levels in hemodialysis patients were higher when compared
to healthy controls (15191378 vs 12849 pg/ml, p<0.0001). Patients with calciﬁed
AVFs had higher serum sclerostin levels than patients with not (18411516 vs
12611173 pg/ml; p¼0,002). Serum sclerostin levels was correlated with AVF
calcium score (r¼0,489, p<0.0001; Figure 1). One-year AVF survival was reduced in
patients with calciﬁed AVFs (Figure 2; HR for AVF thrombosis: 1.88; 95% CI, 1.35-
2.42; p¼0.002). Patients with 25-hydroxy D3 levels greater than median value (21,6
microgr/L; Group 1) were associated with an increase in AVF survival, compared
to patients with 25-hydroxy D3 levels greater than median value and receiving
calcitriol (Group 2), patients with 25-hydroxy D3 levels lower than median value
and receiving calcitriol (Group 3) and ﬁnally patients with 25-hydroxy D3 levels
lower than median value and not receiving calcitriol (Group 4) (Log-rank:
p<0.001). One-year AVF survival was lower with increasing serum sclerostin
quartiles (Log-rank, p¼0.01). Multivariable-adjusted regression analyses revealed
that increased serum sclerostin concentrations were independently associated with
decreased one-year AVF survival (39% decrease per 1-SD increase in sclerostin
concentration, p¼0.001).
Conclusions: Increased serum sclerostin levels appear to be independently associated
with AVF survival and calciﬁcation among hemodialysis patients.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
